Global Neurologic Disorders Therapeutics Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Neurologic Disorders Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Neurologic Disorders Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neurologic Disorders Therapeutics market. Neurologic Disorders Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurologic Disorders Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurologic Disorders Therapeutics market.
A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Neurologic Disorders Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurologic Disorders Therapeutics market. It may include historical data, market segmentation by Type (e.g., Central Nervous System (CNS), Peripheral Nervous System (PNS)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurologic Disorders Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurologic Disorders Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurologic Disorders Therapeutics industry. This include advancements in Neurologic Disorders Therapeutics technology, Neurologic Disorders Therapeutics new entrants, Neurologic Disorders Therapeutics new investment, and other innovations that are shaping the future of Neurologic Disorders Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurologic Disorders Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Neurologic Disorders Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurologic Disorders Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurologic Disorders Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurologic Disorders Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurologic Disorders Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurologic Disorders Therapeutics market.
Market Segmentation:
Neurologic Disorders Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Neurologic Disorders Therapeutics market size was valued at US$ million in 2023. With growing demand in downstream market, the Neurologic Disorders Therapeutics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Neurologic Disorders Therapeutics market. Neurologic Disorders Therapeutics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Neurologic Disorders Therapeutics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Neurologic Disorders Therapeutics market.
A neurological disorder is any disorder of the nervous system. Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Examples of symptoms include paralysis, muscle weakness, poor coordination, loss of sensation, seizures, confusion, pain and altered levels of consciousness. There are many recognized neurological disorders, some relatively common, but many rare.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Neurologic Disorders Therapeutics market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Neurologic Disorders Therapeutics market. It may include historical data, market segmentation by Type (e.g., Central Nervous System (CNS), Peripheral Nervous System (PNS)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Neurologic Disorders Therapeutics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Neurologic Disorders Therapeutics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Neurologic Disorders Therapeutics industry. This include advancements in Neurologic Disorders Therapeutics technology, Neurologic Disorders Therapeutics new entrants, Neurologic Disorders Therapeutics new investment, and other innovations that are shaping the future of Neurologic Disorders Therapeutics.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Neurologic Disorders Therapeutics market. It includes factors influencing customer ' purchasing decisions, preferences for Neurologic Disorders Therapeutics product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Neurologic Disorders Therapeutics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Neurologic Disorders Therapeutics market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Neurologic Disorders Therapeutics market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Neurologic Disorders Therapeutics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Neurologic Disorders Therapeutics market.
Market Segmentation:
Neurologic Disorders Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Central Nervous System (CNS)
- Peripheral Nervous System (PNS)
- Paralysis
- Muscle Weakness
- Poor Coordination
- Loss of Sensation
- Seizures
- Confusion
- Pain and Altered Levels of Consciousness
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Novartis AG
- Pfizer Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurologic Disorders Therapeutics Market Size 2019-2030
2.1.2 Neurologic Disorders Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurologic Disorders Therapeutics Segment by Type
2.2.1 Central Nervous System (CNS)
2.2.2 Peripheral Nervous System (PNS)
2.3 Neurologic Disorders Therapeutics Market Size by Type
2.3.1 Neurologic Disorders Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Neurologic Disorders Therapeutics Segment by Application
2.4.1 Paralysis
2.4.2 Muscle Weakness
2.4.3 Poor Coordination
2.4.4 Loss of Sensation
2.4.5 Seizures
2.4.6 Confusion
2.4.7 Pain and Altered Levels of Consciousness
2.5 Neurologic Disorders Therapeutics Market Size by Application
2.5.1 Neurologic Disorders Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
3 NEUROLOGIC DISORDERS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Neurologic Disorders Therapeutics Market Size Market Share by Players
3.1.1 Global Neurologic Disorders Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Neurologic Disorders Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROLOGIC DISORDERS THERAPEUTICS BY REGIONS
4.1 Neurologic Disorders Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
4.3 APAC Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
4.4 Europe Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
5.2 Americas Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
5.3 Americas Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurologic Disorders Therapeutics Market Size by Region (2019-2024)
6.2 APAC Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
6.3 APAC Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurologic Disorders Therapeutics by Country (2019-2024)
7.2 Europe Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurologic Disorders Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROLOGIC DISORDERS THERAPEUTICS MARKET FORECAST
10.1 Global Neurologic Disorders Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Neurologic Disorders Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Neurologic Disorders Therapeutics Forecast
10.1.3 APAC Neurologic Disorders Therapeutics Forecast
10.1.4 Europe Neurologic Disorders Therapeutics Forecast
10.1.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast
10.2 Americas Neurologic Disorders Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Neurologic Disorders Therapeutics Market Forecast
10.2.2 Canada Neurologic Disorders Therapeutics Market Forecast
10.2.3 Mexico Neurologic Disorders Therapeutics Market Forecast
10.2.4 Brazil Neurologic Disorders Therapeutics Market Forecast
10.3 APAC Neurologic Disorders Therapeutics Forecast by Region (2025-2030)
10.3.1 China Neurologic Disorders Therapeutics Market Forecast
10.3.2 Japan Neurologic Disorders Therapeutics Market Forecast
10.3.3 Korea Neurologic Disorders Therapeutics Market Forecast
10.3.4 Southeast Asia Neurologic Disorders Therapeutics Market Forecast
10.3.5 India Neurologic Disorders Therapeutics Market Forecast
10.3.6 Australia Neurologic Disorders Therapeutics Market Forecast
10.4 Europe Neurologic Disorders Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Neurologic Disorders Therapeutics Market Forecast
10.4.2 France Neurologic Disorders Therapeutics Market Forecast
10.4.3 UK Neurologic Disorders Therapeutics Market Forecast
10.4.4 Italy Neurologic Disorders Therapeutics Market Forecast
10.4.5 Russia Neurologic Disorders Therapeutics Market Forecast
10.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Neurologic Disorders Therapeutics Market Forecast
10.5.2 South Africa Neurologic Disorders Therapeutics Market Forecast
10.5.3 Israel Neurologic Disorders Therapeutics Market Forecast
10.5.4 Turkey Neurologic Disorders Therapeutics Market Forecast
10.5.5 GCC Countries Neurologic Disorders Therapeutics Market Forecast
10.6 Global Neurologic Disorders Therapeutics Forecast by Type (2025-2030)
10.7 Global Neurologic Disorders Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biogen Inc.
11.1.1 Biogen Inc. Company Information
11.1.2 Biogen Inc. Neurologic Disorders Therapeutics Product Offered
11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biogen Inc. Main Business Overview
11.1.5 Biogen Inc. Latest Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Information
11.2.2 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Information
11.3.2 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Services Inc. Main Business Overview
11.3.5 Johnson & Johnson Services Inc. Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Neurologic Disorders Therapeutics Product Offered
11.4.3 Novartis AG Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Information
11.5.2 Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Inc. Main Business Overview
11.5.5 Pfizer Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurologic Disorders Therapeutics Market Size 2019-2030
2.1.2 Neurologic Disorders Therapeutics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Neurologic Disorders Therapeutics Segment by Type
2.2.1 Central Nervous System (CNS)
2.2.2 Peripheral Nervous System (PNS)
2.3 Neurologic Disorders Therapeutics Market Size by Type
2.3.1 Neurologic Disorders Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
2.4 Neurologic Disorders Therapeutics Segment by Application
2.4.1 Paralysis
2.4.2 Muscle Weakness
2.4.3 Poor Coordination
2.4.4 Loss of Sensation
2.4.5 Seizures
2.4.6 Confusion
2.4.7 Pain and Altered Levels of Consciousness
2.5 Neurologic Disorders Therapeutics Market Size by Application
2.5.1 Neurologic Disorders Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
3 NEUROLOGIC DISORDERS THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Neurologic Disorders Therapeutics Market Size Market Share by Players
3.1.1 Global Neurologic Disorders Therapeutics Revenue by Players (2019-2024)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Neurologic Disorders Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEUROLOGIC DISORDERS THERAPEUTICS BY REGIONS
4.1 Neurologic Disorders Therapeutics Market Size by Regions (2019-2024)
4.2 Americas Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
4.3 APAC Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
4.4 Europe Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
4.5 Middle East & Africa Neurologic Disorders Therapeutics Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Neurologic Disorders Therapeutics Market Size by Country (2019-2024)
5.2 Americas Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
5.3 Americas Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurologic Disorders Therapeutics Market Size by Region (2019-2024)
6.2 APAC Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
6.3 APAC Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Neurologic Disorders Therapeutics by Country (2019-2024)
7.2 Europe Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurologic Disorders Therapeutics by Region (2019-2024)
8.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2019-2024)
8.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEUROLOGIC DISORDERS THERAPEUTICS MARKET FORECAST
10.1 Global Neurologic Disorders Therapeutics Forecast by Regions (2025-2030)
10.1.1 Global Neurologic Disorders Therapeutics Forecast by Regions (2025-2030)
10.1.2 Americas Neurologic Disorders Therapeutics Forecast
10.1.3 APAC Neurologic Disorders Therapeutics Forecast
10.1.4 Europe Neurologic Disorders Therapeutics Forecast
10.1.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast
10.2 Americas Neurologic Disorders Therapeutics Forecast by Country (2025-2030)
10.2.1 United States Neurologic Disorders Therapeutics Market Forecast
10.2.2 Canada Neurologic Disorders Therapeutics Market Forecast
10.2.3 Mexico Neurologic Disorders Therapeutics Market Forecast
10.2.4 Brazil Neurologic Disorders Therapeutics Market Forecast
10.3 APAC Neurologic Disorders Therapeutics Forecast by Region (2025-2030)
10.3.1 China Neurologic Disorders Therapeutics Market Forecast
10.3.2 Japan Neurologic Disorders Therapeutics Market Forecast
10.3.3 Korea Neurologic Disorders Therapeutics Market Forecast
10.3.4 Southeast Asia Neurologic Disorders Therapeutics Market Forecast
10.3.5 India Neurologic Disorders Therapeutics Market Forecast
10.3.6 Australia Neurologic Disorders Therapeutics Market Forecast
10.4 Europe Neurologic Disorders Therapeutics Forecast by Country (2025-2030)
10.4.1 Germany Neurologic Disorders Therapeutics Market Forecast
10.4.2 France Neurologic Disorders Therapeutics Market Forecast
10.4.3 UK Neurologic Disorders Therapeutics Market Forecast
10.4.4 Italy Neurologic Disorders Therapeutics Market Forecast
10.4.5 Russia Neurologic Disorders Therapeutics Market Forecast
10.5 Middle East & Africa Neurologic Disorders Therapeutics Forecast by Region (2025-2030)
10.5.1 Egypt Neurologic Disorders Therapeutics Market Forecast
10.5.2 South Africa Neurologic Disorders Therapeutics Market Forecast
10.5.3 Israel Neurologic Disorders Therapeutics Market Forecast
10.5.4 Turkey Neurologic Disorders Therapeutics Market Forecast
10.5.5 GCC Countries Neurologic Disorders Therapeutics Market Forecast
10.6 Global Neurologic Disorders Therapeutics Forecast by Type (2025-2030)
10.7 Global Neurologic Disorders Therapeutics Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 Biogen Inc.
11.1.1 Biogen Inc. Company Information
11.1.2 Biogen Inc. Neurologic Disorders Therapeutics Product Offered
11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Biogen Inc. Main Business Overview
11.1.5 Biogen Inc. Latest Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Information
11.2.2 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 F. Hoffmann-La Roche Ltd. Main Business Overview
11.2.5 F. Hoffmann-La Roche Ltd. Latest Developments
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Information
11.3.2 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Johnson & Johnson Services Inc. Main Business Overview
11.3.5 Johnson & Johnson Services Inc. Latest Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Information
11.4.2 Novartis AG Neurologic Disorders Therapeutics Product Offered
11.4.3 Novartis AG Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Novartis AG Main Business Overview
11.4.5 Novartis AG Latest Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Information
11.5.2 Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Pfizer Inc. Main Business Overview
11.5.5 Pfizer Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Neurologic Disorders Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Central Nervous System (CNS)
Table 3. Major Players of Peripheral Nervous System (PNS)
Table 4. Neurologic Disorders Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Neurologic Disorders Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Neurologic Disorders Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Neurologic Disorders Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Neurologic Disorders Therapeutics Key Players Head office and Products Offered
Table 13. Neurologic Disorders Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Neurologic Disorders Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Neurologic Disorders Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Neurologic Disorders Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Neurologic Disorders Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Neurologic Disorders Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Neurologic Disorders Therapeutics
Table 45. Key Market Challenges & Risks of Neurologic Disorders Therapeutics
Table 46. Key Industry Trends of Neurologic Disorders Therapeutics
Table 47. Global Neurologic Disorders Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Neurologic Disorders Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Neurologic Disorders Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Biogen Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 52. Biogen Inc. Neurologic Disorders Therapeutics Product Offered
Table 53. Biogen Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Biogen Inc. Main Business
Table 55. Biogen Inc. Latest Developments
Table 56. F. Hoffmann-La Roche Ltd. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
Table 58. F. Hoffmann-La Roche Ltd. Main Business
Table 59. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. F. Hoffmann-La Roche Ltd. Latest Developments
Table 61. Johnson & Johnson Services Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 62. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
Table 63. Johnson & Johnson Services Inc. Main Business
Table 64. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Services Inc. Latest Developments
Table 66. Novartis AG Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 67. Novartis AG Neurologic Disorders Therapeutics Product Offered
Table 68. Novartis AG Main Business
Table 69. Novartis AG Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novartis AG Latest Developments
Table 71. Pfizer Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 72. Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
Table 73. Pfizer Inc. Main Business
Table 74. Pfizer Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Inc. Latest Developments
Table 1. Neurologic Disorders Therapeutics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Central Nervous System (CNS)
Table 3. Major Players of Peripheral Nervous System (PNS)
Table 4. Neurologic Disorders Therapeutics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 7. Neurologic Disorders Therapeutics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 10. Global Neurologic Disorders Therapeutics Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Neurologic Disorders Therapeutics Revenue Market Share by Player (2019-2024)
Table 12. Neurologic Disorders Therapeutics Key Players Head office and Products Offered
Table 13. Neurologic Disorders Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Neurologic Disorders Therapeutics Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Neurologic Disorders Therapeutics Market Size Market Share by Regions (2019-2024)
Table 18. Global Neurologic Disorders Therapeutics Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Neurologic Disorders Therapeutics Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Neurologic Disorders Therapeutics Market Size Market Share by Country (2019-2024)
Table 22. Americas Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 24. Americas Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 26. APAC Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region (2019-2024)
Table 28. APAC Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 30. APAC Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 32. Europe Neurologic Disorders Therapeutics Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country (2019-2024)
Table 34. Europe Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 36. Europe Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Neurologic Disorders Therapeutics
Table 45. Key Market Challenges & Risks of Neurologic Disorders Therapeutics
Table 46. Key Industry Trends of Neurologic Disorders Therapeutics
Table 47. Global Neurologic Disorders Therapeutics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Neurologic Disorders Therapeutics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Neurologic Disorders Therapeutics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Biogen Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 52. Biogen Inc. Neurologic Disorders Therapeutics Product Offered
Table 53. Biogen Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Biogen Inc. Main Business
Table 55. Biogen Inc. Latest Developments
Table 56. F. Hoffmann-La Roche Ltd. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 57. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Product Offered
Table 58. F. Hoffmann-La Roche Ltd. Main Business
Table 59. F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. F. Hoffmann-La Roche Ltd. Latest Developments
Table 61. Johnson & Johnson Services Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 62. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Product Offered
Table 63. Johnson & Johnson Services Inc. Main Business
Table 64. Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Johnson & Johnson Services Inc. Latest Developments
Table 66. Novartis AG Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 67. Novartis AG Neurologic Disorders Therapeutics Product Offered
Table 68. Novartis AG Main Business
Table 69. Novartis AG Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Novartis AG Latest Developments
Table 71. Pfizer Inc. Details, Company Type, Neurologic Disorders Therapeutics Area Served and Its Competitors
Table 72. Pfizer Inc. Neurologic Disorders Therapeutics Product Offered
Table 73. Pfizer Inc. Main Business
Table 74. Pfizer Inc. Neurologic Disorders Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. Pfizer Inc. Latest Developments
LIST OF FIGURES
Figure 1. Neurologic Disorders Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurologic Disorders Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurologic Disorders Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurologic Disorders Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Neurologic Disorders Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurologic Disorders Therapeutics Market Size Market Share by Type in 2023
Figure 10. Neurologic Disorders Therapeutics in Paralysis
Figure 11. Global Neurologic Disorders Therapeutics Market: Paralysis (2019-2024) & ($ Millions)
Figure 12. Neurologic Disorders Therapeutics in Muscle Weakness
Figure 13. Global Neurologic Disorders Therapeutics Market: Muscle Weakness (2019-2024) & ($ Millions)
Figure 14. Neurologic Disorders Therapeutics in Poor Coordination
Figure 15. Global Neurologic Disorders Therapeutics Market: Poor Coordination (2019-2024) & ($ Millions)
Figure 16. Neurologic Disorders Therapeutics in Loss of Sensation
Figure 17. Global Neurologic Disorders Therapeutics Market: Loss of Sensation (2019-2024) & ($ Millions)
Figure 18. Neurologic Disorders Therapeutics in Seizures
Figure 19. Global Neurologic Disorders Therapeutics Market: Seizures (2019-2024) & ($ Millions)
Figure 20. Neurologic Disorders Therapeutics in Confusion
Figure 21. Global Neurologic Disorders Therapeutics Market: Confusion (2019-2024) & ($ Millions)
Figure 22. Neurologic Disorders Therapeutics in Pain and Altered Levels of Consciousness
Figure 23. Global Neurologic Disorders Therapeutics Market: Pain and Altered Levels of Consciousness (2019-2024) & ($ Millions)
Figure 24. Global Neurologic Disorders Therapeutics Market Size Market Share by Application in 2023
Figure 25. Global Neurologic Disorders Therapeutics Revenue Market Share by Player in 2023
Figure 26. Global Neurologic Disorders Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 28. APAC Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 29. Europe Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 31. Americas Neurologic Disorders Therapeutics Value Market Share by Country in 2023
Figure 32. United States Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region in 2023
Figure 37. APAC Neurologic Disorders Therapeutics Market Size Market Share by Type in 2023
Figure 38. APAC Neurologic Disorders Therapeutics Market Size Market Share by Application in 2023
Figure 39. China Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country in 2023
Figure 46. Europe Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Europe Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Germany Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. APAC Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Europe Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. United States Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Canada Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. China Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Japan Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Korea Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. India Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Australia Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Germany Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. France Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. UK Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Italy Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Russia Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Spain Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 83. Israel Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 86. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Neurologic Disorders Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurologic Disorders Therapeutics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Neurologic Disorders Therapeutics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Neurologic Disorders Therapeutics Sales Market Share by Country/Region (2023)
Figure 8. Neurologic Disorders Therapeutics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Neurologic Disorders Therapeutics Market Size Market Share by Type in 2023
Figure 10. Neurologic Disorders Therapeutics in Paralysis
Figure 11. Global Neurologic Disorders Therapeutics Market: Paralysis (2019-2024) & ($ Millions)
Figure 12. Neurologic Disorders Therapeutics in Muscle Weakness
Figure 13. Global Neurologic Disorders Therapeutics Market: Muscle Weakness (2019-2024) & ($ Millions)
Figure 14. Neurologic Disorders Therapeutics in Poor Coordination
Figure 15. Global Neurologic Disorders Therapeutics Market: Poor Coordination (2019-2024) & ($ Millions)
Figure 16. Neurologic Disorders Therapeutics in Loss of Sensation
Figure 17. Global Neurologic Disorders Therapeutics Market: Loss of Sensation (2019-2024) & ($ Millions)
Figure 18. Neurologic Disorders Therapeutics in Seizures
Figure 19. Global Neurologic Disorders Therapeutics Market: Seizures (2019-2024) & ($ Millions)
Figure 20. Neurologic Disorders Therapeutics in Confusion
Figure 21. Global Neurologic Disorders Therapeutics Market: Confusion (2019-2024) & ($ Millions)
Figure 22. Neurologic Disorders Therapeutics in Pain and Altered Levels of Consciousness
Figure 23. Global Neurologic Disorders Therapeutics Market: Pain and Altered Levels of Consciousness (2019-2024) & ($ Millions)
Figure 24. Global Neurologic Disorders Therapeutics Market Size Market Share by Application in 2023
Figure 25. Global Neurologic Disorders Therapeutics Revenue Market Share by Player in 2023
Figure 26. Global Neurologic Disorders Therapeutics Market Size Market Share by Regions (2019-2024)
Figure 27. Americas Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 28. APAC Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 29. Europe Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 30. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2019-2024 ($ Millions)
Figure 31. Americas Neurologic Disorders Therapeutics Value Market Share by Country in 2023
Figure 32. United States Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 33. Canada Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Mexico Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Brazil Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 36. APAC Neurologic Disorders Therapeutics Market Size Market Share by Region in 2023
Figure 37. APAC Neurologic Disorders Therapeutics Market Size Market Share by Type in 2023
Figure 38. APAC Neurologic Disorders Therapeutics Market Size Market Share by Application in 2023
Figure 39. China Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 40. Japan Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 41. Korea Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 42. Southeast Asia Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 43. India Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 44. Australia Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Europe Neurologic Disorders Therapeutics Market Size Market Share by Country in 2023
Figure 46. Europe Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Figure 47. Europe Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Figure 48. Germany Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 49. France Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 50. UK Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 51. Italy Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Russia Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Region (2019-2024)
Figure 54. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Type (2019-2024)
Figure 55. Middle East & Africa Neurologic Disorders Therapeutics Market Size Market Share by Application (2019-2024)
Figure 56. Egypt Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 57. South Africa Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 58. Israel Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 59. Turkey Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 60. GCC Country Neurologic Disorders Therapeutics Market Size Growth 2019-2024 ($ Millions)
Figure 61. Americas Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 62. APAC Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 63. Europe Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 64. Middle East & Africa Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 65. United States Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 66. Canada Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 67. Mexico Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 68. Brazil Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 69. China Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 70. Japan Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 71. Korea Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 72. Southeast Asia Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 73. India Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 74. Australia Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 75. Germany Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 76. France Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 77. UK Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 78. Italy Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 79. Russia Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 80. Spain Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 81. Egypt Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 82. South Africa Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 83. Israel Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 84. Turkey Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 85. GCC Countries Neurologic Disorders Therapeutics Market Size 2025-2030 ($ Millions)
Figure 86. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Type (2025-2030)
Figure 87. Global Neurologic Disorders Therapeutics Market Size Market Share Forecast by Application (2025-2030)
